• Latest Posts
Startup Scout 2 Nov 2022

Breakpoint Therapeutics sabotages DNA repair in cancer cells

Partnership for better understanding of Sjögren’s syndrome announced by Evotec

Collaboration will allow Evotec to evaluate small molecules developed by Adapsyn

Biologics manufacturing facility launched by Evotec SE in Toulouse

Evotec SE acquires highly-flexible drug manufacturing space for €1

ADVERTISEMENT

Evotec completes acquisition of Rigenerand

Evotec adds cell therapy manufacturing facility through Rigenerand takeover

Evotec, Sernova in partnership to develop beta cell diabetes therapy

The Billion-Euro European Biotech Companies in 2022

Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks

Farxiga’s Approval Fuels Chronic Kidney Disease Comeback

ADVERTISEMENT